Open Studies catharine February 6, 2020
  • Dogs with Allergic Dermatitis
    ACI is currently enrolling dogs in a multicenter, randomized, placebo-controlled clinical trial to evaluate the safety and effectiveness of an oral therapy for the treatment of pruritus associated to allergic dermatitis.
  • Dogs Scheduled to Receive Doxorubicin Chemotherapy
    ACI is currently enrolling patients in a multicenter, randomized, placebo controlled clinical trial to evaluate the effectiveness of transdermal ondansetron for the prevention of nausea and vomiting in dogs undergoing chemotherapy with doxorubicin.
  • Dogs with Lymphoma (Enrollment has now closed)
    ACI is enrolling dogs in a fully funded, randomized, double-masked, placebo-controlled, clinical study to evaluate the safety and effectiveness of verdinexor for the treatment of naïve or first relapse stages II, III, and IV lymphoma in client owned dogs. Diagnosis of lymphoma must be confirmed by cytology or biopsy for the dog to be eligible for this study.
  • Dogs with Oral Melanoma
    This fully funded, randomized, placebo-controlled clinical trial will assess a potential new treatment for oral melanoma in dogs.

Interested in a study? We can help.

    As a pet parent, we hope you never need us, but we are here when you do.

    Don’t see a study here that meets your current need? We still aim to connect you with others who may be able to help.